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Successful prophylaxis of experimental streptococcal endocarditis with
single doses of sublethal concentrations of penicillin
P. Francioli and M. P. Glauser
Division des Maladies Infectieuses, Departement de Medecine,
Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
Penicillin prophylaxis against experimental endocarditis due to a strain of
Streptococcus intermedus isolated from a patient with endocarditis was studied in
rats. The minimum bactericidal concentration of penicillin for this strain was more
than 64 mg/1 and was higher than the peak penicillin serum level obtained in rats
30 min after the IV injecUon of 60 mg/kg, and in man after an oral dose of 2 g of
phenoxymethyl penicillin. Moreover timed kill curves performed in the presence of
64 mg/1 of penicillin showed no decrease in the number of colony-forming units
during the first 6 h of incubation and only a 95% decrease after 24 h. In addition, no
bactericidal activity could be detected in the serum 30 min after penicillin injection,
that is at the time of bacterial challenge. Using the minimum bactenal inoculum
needed to produce endocarditis in 90% of control animals (ID90), penicillin
successfully prevented endocarditis due to this strain. We conclude that penicillin
may prevent streptococcal endocarditis by other mechanisms than bactenal killing.
Introduction
Penicillin is one of the most commonly recommended antibiotics for prophylaxis of
bacterial endocarditis in susceptible patients undergoing oral procedures. Studies in the
rabbit model of endocarditis have suggested that high and repeated doses of
bactericidal antibiotics, including penicillin, were necessary to achieve successful
protection (Durack & Petersdorf, 1973; Pelletier, Durack & Petersdorf, 1975)
Furthermore, antibiotics like clindamycin or tetracycline were ineffective, suggesting
that bacterial killing was the main mechanism by which antibiotics protected against
endocarditis. However the number of micro-organisms used to induce infection in
these experiments was very high and probably greatly exceeded that found in man
after dental manipulation.
Recent experiments performed with lower inocula have shown that single doses of
vancomycin, amoxicillin and even "bacteriostatic" antibiotics such as clindamycin or
erythromycin were effective in preventing endocarditis (Bernard, Francioli & Glauser,
1981; Glauser & Francioli, 1982; Glauser et al, 1983a). These studies raised the
possibility of mechanisms other than bacterial killing operating to prevent
endocarditis, since protection was achieved in the absence of bactericidal activity of the
antibiotics used for prophylaxis.
Mechanisms of action other than bacterial killing are not only interesting but highly
desirable if one considers that up to 40 to 50% of Streptococcus viridans isolated either
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from the mouth flora (Dankert & Hess, 1982) or from patients with endocarditis
(Glauser el al., 19836) were shown to be tolerant to penicillin or amoxicillin.
The purpose of the present study was to test the efficacy of penicillin, the antibiotic
most commonly used for endocarditis prophylaxis, against a strain of Str. viridans
highly resistant to its bactericidal activity.
Material and methods
Micro-organism
A previously described strain of Str. intermedius isolated from a patient with bacterial
endocarditis was used (Glauser & Francioli, 1982). Minimal inhibitory concentration
(MIC) of penicillin were determined by broth dilution tests, using Mueller-Hinton
broth (Difco Laboratories, Detroit, U.S.A.), and 5 x 105 cfu as the inocula. The minimal
bactericidal concentration (MBC) were determined by subculturing on penicillinase-
containing blood agar plates 01 ml of an undiluted sample. After incubation for 48 h
the number of colonies on each plate was counted, and the MBC was determined as
the lowest dilution of antibiotic that showed 99-9% killing.
Killing curve with 64 mg/1 of penicillin were performed in trypticase soya broth
(Difco Laboratories, Detroit, U.S.A.) using an inoculum of 106 cfu/ml of an overnight
culture of Str. intermedius. This concentration was chosen because it was well above
achievable serum levels obtainable in humans after a 2 g oral dose of phenoxymethyl
penicillin.
Penicillin serum levels and serum bactericidal activity
Serum levels of sodium benzyl penicillin were determined in five rats by an agar
diffusion technique (Sabath & Anhalt, 1980) at 30 min, 1 and 2 h after iv injection of
60 mg/kg. This dosage was chosen because it produces peak serum levels in rats similar
to those achieved in man after an oral dose of 2 g of phenoxymethyl penicillin. The
serum bactericidal activity of penicillin against Str. intermedius was determined by
standard methods (Anhalt, Sabath & Barry, 1980) 30 min after iv injection of 60 mg of
penicillin/kg of body weight. The serum bactericidal activity was defined as the highest
serum dilution that gave 99-9% killing after 24 h of incubation.
Production and prophylaxis of endocarditis
Sterile vegetations were produced in femal Wistar rats (weight 180-200 g) by a
modification of a previously described method. In brief, a polyethylene catheter (model
no. PP10; Portex, Hythe, Kent, England) was passed through the aortic valve via the
right carotid artery and secured with a silk ligature. Twenty-four hours after
catheterization, rats were injected in the tail vein with saline or 60 mg/kg of sodium
penicillin. Thirty minutes later 0-5 ml of saline containing 105 cfu of bacteria, the
minimal inoculum needed to produce endocarditis in more than 90% of control rats,
was injected intravenously (Glauser et al., 1983a). Rats were killed 72 h after bacterial
challenge, and aortic vegetations were excised, weighed, homogenized in 1 ml of 0-85%
NaCl, serially diluted, and plated. Colony counts were done after 48 h of incubation at
37°C.
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Figure 1. Rate of m-vilro lulling of Str intermedium by 64 mg of penicillin/1 a concentration 4 times higher
than the serum level in rats 30 min after the iv injection of 60 mg/kg of penicillin O. Control; • , benzyl
penicillin 64 mg/1
Statistical analysis
The x2 test with Yates's correction was used for statistical comparisons.
Results
Susceptibility of Str. intermedius to penicillin
Minimal inhibitory and bactericidal concentrations for the Str. intermedius of penicillin
were 0032 and >64mg/1 respectively. Survival of Str. intermedius in 64mg/1 of
penicillin showed no decrease in cfu during the first 6 h of incubation and only a
90-99% killing after 24 and 48 h of incubation (Figure 1). Therefore, this Str.
intermedius was tolerant to the bactericidal action of penicillin.
Penicillin serum levels and serum bactericidal activity (Figure 2)
Penicillin serum levels (±s.D.) in 5 rats 30 min, 1 h and 2 h after injection of 60 mg/kg
iv were 16±1, 2 ± 0 1 and approximately 001 mg/1, respectively. There was no
detectable serum bactericidal activity 30 min after injection of penicillin, that is at the
time of injection of bacteria in the prophylaxis experiments.
Prophylaxis of Str. intermedius endocarditis by intravenously administered penicillin
(Figure 3)
The incidence of Str. intermedius endocarditis was reduced from 95% (22/23 rats) in
controls to 20% (4/20) in rats given penicillin 30 min before bacterial challenge
(P<\0-*).
Discussion
Earlier studies in rabbits have shown that high and prolonged serum levels of
bactericidal antibiotics, including penicillin, were necessary for adequate prophylaxis
300 P. Francioli and M. P. Glauser
2 -
2h
Figure 2. Serum levels ( ± S D ) of sodium penicillin 30 mm, 1 h and 2 h after a single IV injection of
60 mg/kg in rats The dotted line represents peak level achieved in humans after an oral dose of 2 g of
phenoxymethyl penicillin
against Str. viridans endocarditis (Durack & Petersdorf, 1973).
Recently, strains of viridans streptococci isolated from the oral flora of children with
cardiac disease (Dankert & Hess, 1982) and from their blood after dental extractions
(Holloway, Dankert & Hess, 1980) were often shown to be tolerant to penicillin. In
addition, we found that 17 out of 25 strains of viridans streptococci isolated from
patients with endocarditis were tolerant to amoxicillin, 13 of them having MBCs
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Figure 3. Incidence of endocarditis due to Str. intermedius after prophylaxis with 60 mg/kg of sodium
penicillin administered iv 30 min before bacterial challenge. Numbers within the bars indicate the number of
rats in each group
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greater than 32 mg/1, a concentration which is higher than the peak serum levels
achieved after a 3 g oral dose (Glauser et al., 1983ft).
To assess whether the phenomenon of in-vitro tolerance holds any significance in
vivo, Hess, Dankert & Durack (1983) studied the ability of penicillin to prevent
experimental endocarditis caused by tolerant and non-tolerant strains of Str. sanguis.
They found that a single dose of penicillin was successful when the strain of
streptococcus was highly sensitive to the bactericidal action of the antibiotic, but was
much less effective when the strains were tolerant and not killed in vitro by
concentrations of penicillin similar to those achieved in vivo. Moreover the efficacy of
penicillin against tolerant strains were greatly increased by the addition of
streptomycin which provided a better bactericidal activity. These results were
interpreted as showing that killing was indeed a critical factor for efficacy of
prophylaxis and, because of the occurrence of tolerance among viridans streptococci,
this raises concern about the efficacy of the single dose amoxicillin regimen recently
recommended by the Working Party of the British Society for Antimicrobial
Chemotherapy (1982).
In contrast to the experiments mentioned above (Durack and Petersdorf, 1973;
Hess, Dankert and Durack 1983), we and others recently found that single doses of
vancomycin (Bernard et al., 1981; Scheld et al., 1981), amoxicillin (Glauser et al., 1983a)
and even bacteriostatic antibiotics (Glauser & Francioh, 1982) could afford excellent
protection against Str. viridans endocarditis in the absence of bacterial killing. With
the present study, penicillin can be added to the list of antibiotic operating in the
absence of bacterial killing. Indeed, the Str. intermedius strain had a MBC for
penicillin much higher than the peak serum level of the antibiotic and therefore was
not expected to be killed by the drug in vivo. This was also attested by the killing
curves and the absence of any detectable bactericidal activity in the serum at the time
of injection of the bacteria.
The discrepancy between the present results and those of Durack & Petersdorf
(1973) and Hess et al. (1983) regarding the requirement for penicillin to be bactericidal
in order to prevent endocarditis might be explained by the differences in the size of the
inocula used for bacterial challenge. Indeed, we have shown in rats that streptococcal
endocarditis can be efficiently prevented by single doses of non-bactericidal
concentrations of amoxicillin, provided that, like in the present experiment, the
inoculum size is not higher than the minimum inoculum able to induce endocarditis in
90% of control animals (ID90). With higher inocula the efficacy of prophylaxis of
amoxicillin was abolished unless the strain of streptococcus used was highly sensitive
to the bactericidal action of the drug (Glauser et ai, 1983a). Therefore, a bactericidal
activity appears to be required for efficient prophylaxis only when infection is induced
by inocula 10 or 100 times higher than the ID9 0 . Durack & Petersdorf (1973) used an
inoculum of 108 cfu and presented evidence that this inoculum was much higher than
the ID9 0 (Pelletier, Durack & Petersdorf, 1975). Hess, Dankert & Durack (1983) used
an inoculum of 107 cfu, a size which is likely to be also above the ID9 0 . In contrast, the
present experiments using penicillin as prophylactic antibiotic were earned out with an
inoculum known to be close to the ID9 0 (Glauser et al., 1983a). These differences in
inoculum size probably explain why, in the absence of killing, penicillin prevented
endocarditis in the present experiment, while it did not in other studies. Even though
the inoculum we used was smaller, it provides a stringent test of antibiotic prophylaxis
because the resulting bacteraemia is far greater than that observed in humans after
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oral procedure (Petersdorf, 1978) and produces 80-100% endocarditis in animals.
The mechanisms by which antibiotics can prevent endocarditis in the absence of
killing are not completely elucidated. The cell-wall active antibiotics such as penicillin,
amoxicillin or vancomycin have been shown in vitro to interfere with streptococcal
adhesiveness to platelets fibrin matrices mimiking cardiac vegetations. Moreover there
are in-vivo experimental suggestions that inhibition of adherence might be one of the
mechanisms of action of antibiotics involved in endocarditis prophylaxis. (Scheld et
al., 1981; Lowy et al, 1983; Glauser et al, 1983a).
Whatever the mechanism of protection, the present experiment demonstrates that
short-lived serum levels of penicillin similar to those achieved in man after an oral dose
of 2 gm of phenoxymethyl penicillin can efficiently prevent the development of
endocarditis, provided the bacterial inoculum size used for challenge is limited to the
ID9 0 .
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